-
www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/low-dose-aspirin-use-for-the-prevention-of-morbidity-and-mortality-from-preeclampsia-preventive-medication
September 28, 2021 -
Scope of Review
An analytic framework was developed … comparisons of effects by population risk of preeclampsia, studies in which more than 12% of participants developed … before delivery, 30 , 38 , 42-44 , 46-48 as early as 34 weeks, 43 or at the point when preeclampsia developed … Only 1 trial used a previously developed risk prediction model. 93 Reviews comparing the test performance … hypertension, multifetal gestation, previous preeclampsia
60
13 to 26 wk; delivery or if preeclampsia developed
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/Qpv8h6ZMbYLYzakVrNQoj2
October 11, 2022 - were fair
or good methodological quality, and were conducted in countries
categorized as very highly developed … The strength of evidence was assessed as high, moderate, low,
or insufficient using methods developed … USPSTF and the
AHRQ Evidence-based Practice Center program.7,19 Two senior re-
viewers independently developed … all medi-
cal settings, including outpatient practices.83 The National Insti-
tute for Mental Health developed … ROBIS: a new tool to assess risk of bias in
systematic reviews was developed.
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/-KMSTWRT9xbm7spaqDq_GE
February 12, 2019 - One investigator
extracted study-level data using data entry forms developed in
DistillerSR (Evidence … The intervention
categories were developed post hoc, and some trials were difficult
to categorize and … Tourne indicates a psychosomatic humanist group intervention
developed by Dr Claude-Emile Tourne. … effective in health care settings outside the United States, sug-
gesting that similar interventions developed … Reasonably
consistent,
imprecise
One study reported results only for
the subset of women who had not
developed
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/_qPVhJ_u9tV9kyAejLM9TB
May 01, 2015 - at the Agency for Healthcare Research Quality and members of the US Preventive Services Task Force developed … METHODS
Following the USPSTF Procedure
Manual,20 we developed an analytic
framework (Supplemental Fig … , and study
designs) approach to identify studies
that met inclusion and exclusion
criteria that we developed
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/gRNjNsmqZvBC-DnHGRMgG3
December 01, 2014 - By
using prespecified criteria for RCTs, cohort, and diagnostic
accuracy studies developed by the USPSTF … valid-
ity (quality) of the body of evidence for the new studies for
each key question using methods developed … discharge), 0.6% (5 of 787) of screened participants
versus 1.6% (14 of 861) of control participants developed … Screening criteria were developed on the basis of question-
naire responses from sexually active participants
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/KSYrhQuAswGjTww_4sDFGZ
December 01, 2007 - METHODS
The USPSTF developed 2 key questions to be ad-
dressed: 1) What are the benefits of screening … Placebo for 4 y
Candesartan, 16 mg, for 2 y,
then placebo for 2 y
3-wk run-in period
If hypertension developed
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/intimate-partner-violence-and-elderly-abuse-screening-2004
March 08, 2004 - Instruments to screen for intimate partner violence have also been developed, and although some have … Caregiver Abuse Screen [CASE] and the Hwalek-Sengstock Elder Abuse Screening Test [HSEAST]) have been developed
-
www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary15/blood-pressure-in-adults-hypertension-screening-2007
October 15, 2007 - Methods
The USPSTF developed … Candesartan, 16 mg, for 2 y, then placebo for 2 y
3-wk run-in period
If hypertension developed
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/d8DVjQhw6JgjWaBtED97s6
The research developed will be
reviewed according to standard USPSTF criteria for inclusion in its evidence
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/aRJ-3-AWuVvmC_kmoGCVHp
The research developed will be reviewed according to standard USPSTF criteria for inclusion in its evidence
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/bJo9H35qzP9xT2qsH8cMwk
February 01, 2016 - updated final recom-
mendation statement on screening mammography for
breast cancer (1)—a guideline developed
-
www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/current-members/james-stevermer-md-msph
January 01, 2021 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
James Stevermer, M.D., M.S.P.H.
Member
James Stevermer, M.D., M.S.P.H., is vice chair for academic affairs and the Paul Revare, M.D., professor of family and community medi…
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/anxiety-adults-screening
June 20, 2023 - and 75% had a lifetime comorbid anxiety disorder. 1 , 11
Screening Tests
Brief tools have been developed … Inventory (GAI). 1 Some instruments that are used for screening for anxiety disorders were initially developed … Transdiagnostic treatment approaches have also been developed for use with patients who have anxiety
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/2024-06/USPSTF-40th-anniversary-timeline_0.pdf
January 01, 2024 - Celebrating 40 years of Prevention Guidance
Celebrating 40 years
of Prevention Guidance
For 40 years, the U.S. Preventive Services Task Force (USPSTF or Task Force) has improved
the health of people nationwide by making evidence-based recommendations on
preventive servi…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obstructive-sleep-apnea-in-adults-screening
March 04, 2021 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Research Plan
Obstructive Sleep Apnea in Adults: Screening
March 04, 2021
Recommendations made by the USPSTF are independent of the U.S. government. They should not be …
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/asymptomatic-bacteriuria-adults-screening-1996
January 01, 1996 - Three subsequently developed cystitis and 20% had recurrences of asymptomatic bacteriuria, but none had … Forty infants developed symptomatic urinary tract infection in the first year of age, but only 2 (5%) … 8 However, these infants might have been detected outside the screening program as their symptoms developed
-
www.uspreventiveservicestaskforce.org/home/getfilebytoken/ER_LzXdmdRcZ463r4UrGtz
September 01, 2005 - Although several tools to predict risk for deleterious
BRCA mutations have been developed from data on … Three tools have been developed to guide
primary care clinicians in assessing risk and guiding refer- … The Manchester
scoring system was developed in the United Kingdom to
predict deleterious BRCA1 or BRCA2
-
www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/cervical-cancer-screening-adults-adolescents
October 28, 2021 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
in progress
Draft Research Plan
Cervical Cancer: Screening
October 28, 2021
Recommendations made by the USPSTF are independent of the U.S. government. They should not be co…
-
www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/folic-acid-for-the-prevention-of-neural-tube-defects-preventive-medication
October 21, 2021 - Share to Facebook
Share to X
Share to WhatsApp
Share to Email
Print
Final Research Plan
Folic Acid Supplementation to Prevent Neural Tube Defects: Preventive Medication
October 21, 2021
Recommendations made by the USPSTF are independent of th…
-
www.uspreventiveservicestaskforce.org/uspstf/sites/default/files/inline-files/2021-uspstf-annual-report-to-congress.pdf
January 01, 2021 - These organizations and
agencies provide input on the recommendations as they are being developed and